-
Roche Puts Alzheimer's Candidate, Gantenerumab In Spotlight; In Dialogue with FDA: Reuters
Thursday, July 22, 2021 - 1:31pm | 353Read More...Roche Holding AG (OTC: RHHBY) is reportedly talking to the FDA about its Alzheimer’s disease drug candidate, gantenerumab. CEO Severin Schwan declined to speculate on the outcome of the talks, Reuters reported. The accelerated approval of Biogen’s Aduhelm has...
-
Intel Costa Rica Ramps Up Chip Plant Investment To $600M: Reuters
Wednesday, July 21, 2021 - 1:10pm | 149Read More...Intel Corp (NASDAQ: INTC) Costa Rica almost doubled a proposed investment in a microchip plant in the Central American country from $350 million to $600 million, Reuters reported. The ramp-up was due to higher demand for chips from the U.S. The chipmaker aims to triple the...
-
YouTube Adds Fourth Monetizing Feature For Creators As Competition With Facebook Intensifies
Tuesday, July 20, 2021 - 2:16pm | 308Read More...Alphabet Inc's (NASDAQ: GOOG) (NASDAQ: GOOGL) YouTube launched a new way for video creators to earn money from fans through a feature called Super Thanks, the company said in its blog. It marks the fourth way for YouTubers to earn money from their viewers as it intensifies...
-
Duolingo Targeting $3.4B IPO Stemming From Online Learning Boom: Reuters
Monday, July 19, 2021 - 2:37pm | 230Read More...Language-learning app maker Duolingo Inc (NASDAQ: DUOL) is aiming for a $3.41 billion U.S. initial public offering to tap the pandemic-driven growing demand for online education tools, Reuters reports. It plans to raise over $485 million by offering 5.1 million shares between $85 -$...
-
Johnson & Johnson Legal Representatives Exploring Putting Talc Lawsuits Into Subsidiary For Bankruptcy Filing: Reuters
Monday, July 19, 2021 - 8:25am | 361Read More...Johnson & Johnson (NYSE: JNJ) is exploring a plan to offload liabilities from its Baby Powder litigation into a newly created business that would then seek bankruptcy protection, Reuters reports. During settlement discussions, one of the Company's attorneys has told plaintiffs...
-
Pfizer To Pay $345M To Resolve EpiPen Pricing Lawsuit: Reuters
Friday, July 16, 2021 - 8:42am | 320Read More...Pfizer Inc (NYSE: PFE) has agreed to pay $345 million to resolve claims by consumers claiming they overpaid for EpiPens due to anti-competitive and unfair practices, reports Reuters. The proposed class action settlement was disclosed in a filing in federal court in Kansas City, Kansas....
-
Crypto-Friendly UK Challenger Bank Revolut Now Worth $33B After SoftBank Investment
Thursday, July 15, 2021 - 3:41pm | 374Read More...British Bitcoin-supporting (CRYPTO: BTC) challenger digital bank Revolut raised around $800 million in a funding round led by Japanese investment behemoth SoftBank Group Corp (TYO: 9984). What Happened: According to a Thursday Reuters report, with this fundraising, Revolut...
-
Comcast Notes Double Digit Ad Rate Surge For Fall TV Season: Reuters
Thursday, July 15, 2021 - 11:00am | 261Read More...Comcast Corp's (NASDAQ: CMCSA) advertising rates and the ad inventory volume sold for the fall television season surged by double-digit percentages year-on-year, Reuters reports. The NBCUniversal parent sought sponsors for inventory, including the upcoming 2022 Winter Olympics and...
-
Illumina, Grail Merger Faces Full-Scale European Probe Amid Antitrust Concerns: Reuters
Wednesday, July 14, 2021 - 11:50am | 296Read More...The proposed $8 billion merger between liquid biopsy firm Grail Inc and cancer blood screening firm Illumina Inc (NASDAQ: ILMN) has met with nothing but flack since it was first announced in September. In March, Federal Trade commissioners voted 4-0 to challenge the deal...
-
After FDA Warning, EMA Reviewing J&J COVID-19 Jab For Rare Nerve Disorder: Reuters
Tuesday, July 13, 2021 - 12:39pm | 286Read More...On Tuesday, the European Medicines Agency (EMA) said it was analyzing data on rare cases of a nerve disorder reported among recipients of Johnson & Johnson's (NYSE: JNJ) COVID-19 shot, Reuters reported. The FDA issued a warning that there are data "...
-
Alibaba Eyes Stake In Chinese Cloud Computing Infrastructure Firm: Report
Tuesday, July 13, 2021 - 11:13am | 394Read More...Alibaba Group Holding Limited (NYSE: BABA), which has a thriving cloud business, is contemplating a deal to strengthen the unit. What Happened: Alibaba, along with Chinese state-backed companies, are exploring the possibility of picking up a stake in the Shenzhen-listed cloud computing...
-
Twitter Gains Compliance With Indian IT Rules: Reuters
Monday, July 12, 2021 - 7:23am | 148Read More...Twitter Inc (NYSE: TWTR) appointed a resident grievance officer, days after designating a chief compliance officer for its India unit to comply with the country’s latest IT rules, Reuters reports. Vinay Prakash was named the new grievance officer. The social media company lost...
-
Certain European Countries Order 40M Additional J&J COVID-19 Jabs: Reuters
Wednesday, July 7, 2021 - 12:27pm | 308Read More...The European Union countries reportedly ordered nearly 40 million additional doses of the COVID-19 vaccine produced by Johnson & Johnson (NYSE: JNJ), a spokesman for the EU Commission said. EU nations initially ordered 200 million doses of the J&J vaccine and could buy up to...
-
Mortgage Software Platform Blend Targets $4B Valuation In US IPO: Reuters
Tuesday, July 6, 2021 - 3:40pm | 248Read More...Digital banking platform Blend Labs Inc (NYSE: BLND) is seeking a valuation of nearly $4 billion in its confidential U.S. initial public offering (IPO) filing, Reuters reports. Blend will list on the NYSE under the symbol "BLND." It aims to capitalize on the demand boom...
-
South Korea Negotiating With mRNA COVID-19 Vaccine Makers To Produce Up To 1B Doses: Reuters
Tuesday, July 6, 2021 - 2:24pm | 352Read More...South Korea is reportedly in talks with mRNA vaccine makers, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), to produce COVID-19 shots in the country. The country is ready to offer the capacity to make up to 1 billion doses immediately, Reuters...
















